Work

BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non–Small Cell Lung Cancer

Year: 2026

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco-25-02696

Authors: Jordi Remon, Tina Cascone, Solange Peters

Institutions: Université Paris-Saclay, Institut Gustave Roussy, The University of Texas MD Anderson Cancer Center, Centre Hospitalier Universitaire Vaudois

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7125522527

FWCI: 18.47

Cites: 18

Cited by: 4

Related to: